INS and hyperinsulinemic hypoglycemia: Critical sampling demonstrated inappropriately detectable insulin and C-peptide, absent ketonuria, suppressed β-hydroxybutyrate, and a diagnostically significant glycemic response to glucagon, confirming hyperinsulinemic hypoglycemia (HH) consistent with congenital hyperinsulinism (CHI).